Guru Ownership Trend
Guru Analysis for Inhibrx Biosciences, Inc. (INBX)
Inhibrx Biosciences, Inc. (INBX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $127.65 M.
Top institutional holders include Andreas Halvorsen and Jefferies Group.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $19.61 M net outflow during the quarter.
Recent activity highlights John Hussman who opened a new position. Conversely, Andreas Halvorsen reduced exposure by 21.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Inhibrx Biosciences, Inc. (INBX)
Major holders include Andreas Halvorsen ($106.49 M), Jefferies Group ($6.96 M), Renaissance Technologies (RenTech) ($5.89 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 1.33 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $19.61 M, with 5 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited INBX. The total reported sell value was $29.73 M.
Yes, 2 managers opened new positions in INBX, and 3 increased their existing holdings. The total reported buy value was $10.12 M.